28Mar/14

Factors driving oncologists' prescribing decisions for HER2-positive breast … – The Pharma Letter

Factors driving oncologists’ prescribing decisions for HER2-positive breast
The Pharma Letter
Afinitor/exemestane: Among surveyed oncologists who do not currently prescribe Afinitor (everolimus)/exemestane to their eligible HR-positive patients, high cost compared with generically available treatments and lack of familiarity with Afinitor

28Mar/14

Former Olympic 400m bronze medalist Donna Hartley-Wass has died from heart … – Daily Mail


Daily Mail

Former Olympic 400m bronze medalist Donna Hartley-Wass has died from heart
Daily Mail
‘She had none of the common features of liver failure,’ he added. However he did discover a pigment in her heart which is normally only … ‘I don’t know whether this caused heart failure. I couldn’t see anything which suggests that to be the cause. We

and more »

28Mar/14

Cornwall nurse in plea over organ donation – Western Morning News


Laois Nationalist

Cornwall nurse in plea over organ donation
Western Morning News
The specialist nurse from the Royal Cornwall Hospital will talk to members about organ donation and signing up to the NHS Organ Donor Register, as well as making sure loved ones are informed about the decision. “Organ donation saves lives and families …
‘I feel very lucky’ – Laois transplant recipient shares her experienceLaois Nationalist
READER SUBMITTED: LifeChoice Team Transplant Of CT Fundraiser BreakfastHartford Courant

all 3 news articles »

28Mar/14

Pre-market Gainers: BofI Holding, Inc. (NASDAQ:BOFI), Hansen Medical, Inc … – Gaining Green

Pre-market Gainers: BofI Holding, Inc. (NASDAQ:BOFI), Hansen Medical, Inc
Gaining Green
Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced that the European Commission (EC) has approved Roche’s new subcutaneous (SC) formulation of MabThera® (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell …

and more »